Skip to main content
. Author manuscript; available in PMC: 2015 Feb 16.
Published in final edited form as: Mol Imaging. 2013 Jan-Feb;12(1):17–27.

Figure 3.

Figure 3

Biodistribution of 89Zr-panitumumab in A431, HCT116, T47D, and MDA-MB435 xenograft models at 24 (A) and 120 (B) hours postinjection. A 1 mg blocking dose of panitumumab was administered 120 minutes prior to administration of 89Zr-panitumumab. Data are expressed as percent injected dose per gram ± standard deviation, n = 5 for each time point.